Kempner, W.: Treatment of hypertensive vascular disease with rice diet. Am. J. Med., 4: 545, 1948.
2.
Perry, H.M., Schroeder, H.A., Catanzaro, F.J., et al.: Studies on the control of hypertension. Mortality, morbidity, and remissions during twelve years of intensive therapy. Circulation, 33: 958-972, 1966.
3.
Volhard, F., Fahr, K.T.: Die Brightsche Nierenkranheit: Klinik, Pathologie und Atlas. Berlin, Springer, 1914 .
4.
McMichael, J. , Murphy, E.A.: Methonium treatment of severe and malignant hypertension. J. Chronic. Dis., 1: 527, 1955.
5.
Perera, G.A. : Hypertensive vascular disease: Description and natural history. J. Chronic. Dis., 1: 33, 1955.
6.
Onesti, G., Kim, K.E., Swartz, C.: The malignant phase of essential hypertension, Hypertension: Mechanisms and Management. New York, Grune & Stratton, 1973, p. 207.
7.
Zacherle, B.J. , Richardson. J.A.: Irreversible renal failure secondary to hypertension induced by oral contraceptives. Ann. Intern. Med., 77: 83-85, 1972.
8.
Moriyama, I.M., Krueger, D.E., Stamler, J.: Cardiovascular diseases in the United States. Cambridge , Harvard University Press, 1971 .
9.
McCormack, L.J. , Beland, J.E., Schneckloth , R.E.: Effect of antihypertensive treatment on the evolution of the renal lesions in malignant hypertension . Am. J. Pathol., 34: 1011-1021, 1958 .
10.
Pickering, G.W., Wright, A.D., Heptinstall , R.H.: The reversibility of malignant hypertension . Lancet, 1: 952-956, 1952.
11.
Pickering, G.: Reversibility of malignant hypertension. Followup of three cases. Lancet, 1: 413-418, 1971.
12.
McCormack, L.J., Beland, J.E., Schneckloth , R.E.: Effect of antihypertensive treatment on the evolution of the renal lesions in malignant hypertension . Am. J. Pathol., 34: 1011-1021, 1958 .
13.
Harington, M., Kincaid-Smith, P., McMichael , J.: Results of treatment in malignant hypertension . Br. Med. J., 2: 969-980, 1959.
14.
Allison, P.R. , Bleehan, N., Brown , W., et al.: The production and resolution of hypertensive vascular lesions in the rabbit. Clin. Sci., 33: 39-51, 1967.
15.
Freis, E.W. , Ragan, D., Pillsbury , H., et al.: Alteration of the course of hypertension in the spontaneously hypertensive rat. Circ. Res., 31: 1-7, 1972.
16.
Sanerkin, N.G. : Vascular lesions of malignant essential hypertension . J. Pathol., 103: 177-184, 1970.
17.
Sevitt, L.H. , Evans, D.J., Wrong , O.M.: Acute oliguric renal failure due to accelerated (malignant) hypertension. Q. J. Med., 157: 127-144, 1971.
18.
Mroczek, W.J. , Finnerty, F.A., Jr.: The Vicious Circle of Hypertension . Evansville, Indiana, Mead Johnson & Co., 1975.
19.
McAllister, R.G., Van Way, C.W., Dayani , K., et al.: Malignant hypertension: Effect of therapy on renin and aldosterone. Circ. Res., 28: 160, 1971.
20.
Johnson, J.G. , Lee, S., Acchiardo, S., et al.: Normal plasma renin activity in malignant hypertension. J. Clin. Invest.52: 43a, 1973 (abstr.).
21.
Gavras, H., Brunner, H.R., Larach, J.H., et al.: Malignant hypertension resulting from deoxycorticosterone acetate and salt excess. Circ. Res., 36: 300, 1975.
22.
Giese, J.: Renin, angiotensin and hypertensive vacular damage: A review. Am. J. Med., 55: 315, 1973.
23.
Merrill, J.P. : Hypertensive vascular disease, Principles of Internal Medicine. New York, McGraw-Hill , 1962, p. 1359.
24.
Woods, J.W. , Blythe, W.B.: Management of malignant hypertension complicated by renal insufficiency. N. Engl. J. Med., 277: 57-62, 1967.
25.
Mroczek, W.J. , Davidov, M.E., Gavrilovich , L., et al.: The value of aggressive therapy in the hypertensive patient with azotemia. Circulation, 40: 893-904, 1969.
26.
Gifford, R. W.Jr.: The treatment of hypertensive emergencies . Am. J. Cardiol., 9: 880-887, 1962.
27.
Finnerty, F.A. Jr., Kakaviatos, N., Tuckman , J., et al.: Clinical evaluation of diazoxide: A new treatment for acute hypertension. Circulation , 28: 203, 1963.
28.
Vertes, V., Cangiano, J.L., Berman, L.B., et al.: Hypertension in end-stage renal disease. N. Engl. J. Med., 280: 978-981, 1969.